5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
US4788181A · kind A · utility
36Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 1986 |
| Grant date | Nov 29, 1988 |
| Priority date | — |
| Expiry date | Sep 29, 2006 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
5-substituted 2',3'-dideoxycytidine compounds and their monophosphates are disclosed which have been found to have potent activity against retroviruses. The 5-fluoro-and 5-aza-substituted 2',3'-dideoycytidine compounds have been found to be effective against HTLV-III/LAV virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.